Comparative in vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

被引：67

作者：

Goldstein, EJC

Citron, DM

Merriam, CV

Warren, Y

Tyrrell, KL

机构：

[1] Univ Calif Los Angeles, Med Ctr, RM Alden Res Lab, Santa Monica, CA 90404 USA

[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 09期

关键词：

D O I：

10.1128/AAC.44.9.2389-2394.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

By using an agar dilution method, the comparative in vitro activities of ertapenem (MK-0826) were studied against 1,001 anaerobes isolated from human intra-abdominal infections in 17 countries worldwide. MK-0826 was uniformly active against all isolates, including all Bacteroides fragilis group species isolates, with the exception of 12 of 61 (20%) strains of Bilophila wadsworthia, 3 strains of lactobacilli, and 1 isolate of Acidaminococcus fermentans. Geographical variation in activity was not observed.

引用

收藏

页码：2389 / 2394

页数：6

相关论文

共 15 条

[1]

[Anonymous], NCCLS PUBL

[2] SUSCEPTIBILITY PATTERNS AND RESISTANCE TO IMIPENEM IN THE BACTEROIDES-FRAGILIS GROUP SPECIES IN JAPAN - A 4-YEAR STUDY [J].

BANDOH, K ;

UENO, K ;

WATANABE, K ;

KATO, N .

CLINICAL INFECTIOUS DISEASES, 1993, 16 :S382-S386

[3] SURVIVAL OF ANAEROBES IN ORIGINAL SPECIMENS TRANSPORTED BY OVERNIGHT MAIL SERVICES [J].

BARON, EJ ;

STRONG, CA ;

MCTEAGUE, M ;

VAISANEN, ML ;

FINEGOLD, SM .

CLINICAL INFECTIOUS DISEASES, 1995, 20 :S174-S177

[4] THE BACTERIOLOGY OF GANGRENOUS AND PERFORATED APPENDICITIS - REVISITED [J].

BENNION, RS ;

BARON, EJ ;

THOMPSON, JE ;

DOWNES, J ;

SUMMANEN, P ;

TALAN, DA ;

FINEGOLD, SM .

ANNALS OF SURGERY, 1990, 211 (02) :165-171

[5] In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests [J].

Fuchs, PC ;

Barry, AL ;

Brown, SD .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) :703-706

[6] In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345) [J].

Gill, CJ ;

Jackson, JJ ;

Gerckens, LS ;

Pelak, BA ;

Thompson, RK ;

Sundelof, JG ;

Kropp, H ;

Rosen, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1996-2001

[7] ANNUAL INCIDENCE, EPIDEMIOLOGY, AND COMPARATIVE INVITRO SUSCEPTIBILITIES TO CEFOXITIN, CEFOTETAN, CEFMETAZOLE, AND CEFTIZOXIME OF RECENT COMMUNITY-ACQUIRED ISOLATES OF THE BACTEROIDES-FRAGILIS GROUP [J].

GOLDSTEIN, EJC ;

CITRON, DM .

JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (11) :2361-2366

[8]

Holdeman LV., 1977, Anaerobic laboratory manual, V4

[9] Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens [J].

Jacoby, G ;

Han, P ;

Tran, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1830-1831

[10] In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum β-lactamase- and extended-spectrum p-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates [J].

Kohler, J ;

Dorso, KL ;

Young, K ;

Hammond, GG ;

Rosen, H ;

Kropp, H ;

Silver, LL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1170-1176